Adjuvant therapy for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study

被引：0
|
作者：
Chen, C-H. [1 ,2 ]
Wu, S-Y. [3 ]
机构：
[1] Taipei Med Univ, Wan Fang Hosp, Dept Colorectal Surg, Taipei, Taiwan
[2] Taipei Med Univ, Municipal Wan Fang Hosp, Taipei, Taiwan
[3] Taipei Med Univ, Municipal Wan Fang Hosp, Dept Radiat Oncol, Taipei Med, Taipei, Taiwan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon
    Emile, Sameh Hany
    Horesh, Nir
    Garoufalia, Zoe
    Gefen, Rachel
    Strassmann, Victor
    Wexner, Steven D.
    CLINICAL COLORECTAL CANCER, 2024, 23 (01) : 35 - 45
  • [42] Improved survival benefit of radiation therapy after surgery in patients with stage IV rectal cancer: A retrospective population-based and propensity score-matched study
    Liu, Q.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
    Lin, Yen-Kuang
    Hsieh, Mao-Chih
    Chang, Chia-Lun
    Chow, Jyh-Ming
    Yuan, Kevin Sheng-Po
    Wu, Alexander T. H.
    Wu, Szu-Yuan
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 326 - 332
  • [44] Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database
    Horesh, Nir
    Emile, Sameh H.
    Garoufalia, Zoe
    Gefen, Rachel
    Zhou, Peige
    Nagarajan, Arun
    Wexner, Steven D.
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (08) : 342 - 350
  • [45] Neoadjuvant versus adjuvant chemoradiotherapy for stage II-III esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Lv, Jiahua
    Li, Tao
    Wang, Qifeng
    Han, Yongtao
    Song, Yuzhe
    Liang, Long
    Chen, Meihua
    Fan, Yu
    Wu, Lei
    Peng, Lin
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study
    Booth, Christopher M.
    Nanji, Sulaiman
    Wei, Xuejiao
    Peng, Yingwei
    Biagi, James J.
    Hanna, Timothy P.
    Krzyzanowska, Monika K.
    Mackillop, William J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (01): : 47 - +
  • [47] Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study
    Rosberg, Victoria
    Jessen, Mikkel
    Qvortrup, Camilla
    Smith, Henry George
    Krarup, Peter-Martin
    ACTA ONCOLOGICA, 2023, 62 (09) : 1076 - 1082
  • [48] Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
    Hu, Huabin
    Wu, Zehua
    Wang, Chao
    Huang, Yan
    Zhang, Jianwei
    Cai, Yue
    Xie, Xiaoyu
    Li, Jianxia
    Shen, Cailu
    Li, Weiwei
    Ling, Jiayu
    Xu, Xuehu
    Deng, Yanhong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [50] Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study
    Yi-Hsuan Wu
    Jhen-Hao Jhan
    Hung-Lung Ke
    Shih-I Tseng
    Yu-Han Chang
    Hsin-Chih Yeh
    Ching-Chia Li
    Yung-Chin Lee
    International Journal of Clinical Pharmacy, 2020, 42 : 1433 - 1439
12345